
Biomarx
Biomarx delivers rapid, low-cost, fully automated liquid biopsy — genomic-grade cancer answers from a blood test in under 2 hours, starting with lung cancer.
$940K Pre Seed ·
Source: startupintros.com
Funding history ↓Signals
Website registeredFeb 6, 2025 (21 months old)
Funding rounds
- Pre Seed · $940KSource: startupintros.com
- Website created
Founders and team
SM
Sean Macfarlane Founder & CEOsource: biomarx.co.uk
Companies like Biomarx
PProthea TechnologiesSeries A · Apr 2025
MmDETECT$3M Seed · May 2026
TTvaster Genkalp$1.25M Series A · Apr 2025DDxcover$6.2M Series A · Feb 2025
EElypta$21M · Jun 2022
OOncoliqSeed · Jul 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/biomarx (get a free API key).